A rare case of oligodendroglioma with gangliocytic differentiation in a 31-year-old male: importance of genetic testing for IDH1/2.
Ji Hyun ParkYoon Jin ChaJong Hee ChangSeung-Koo LeeSe-Hoon KimPublished in: Brain tumor pathology (2020)
We report a rare case of oligodendroglioma with gangliocytic differentiation. A 31-year-old male without a past medical history was admitted with a sudden seizure. On magnetic resonance imaging, an approximately 7-cm mass with necrosis was noted in the right frontal lobe. The patient underwent surgical resection. On microscopy, two morphologically distinct areas with oligodendroglioma- and ganglioglioma-like features were found. Immunohistochemistry showed an absence of CD34 expression, whereas isocitrate dehydrogenase 1 (IDH1) was positive in the glial component. Moreover, IDH1 was positive in the ganglion-like cells as well as in the glial component. Subsequent 1p/19q co-deletion was confirmed by fluorescence in situ hybridization. Finally, a diagnosis of oligodendroglioma with gangliocytic differentiation was made. IDH1/2 molecular test would be basic and essential diagnostic tool in central nervous system tumor of young patients.
Keyphrases
- rare case
- low grade
- wild type
- magnetic resonance imaging
- end stage renal disease
- single molecule
- neuropathic pain
- ejection fraction
- newly diagnosed
- chronic kidney disease
- poor prognosis
- healthcare
- peritoneal dialysis
- high resolution
- high grade
- prognostic factors
- computed tomography
- working memory
- functional connectivity
- spinal cord injury
- magnetic resonance
- mass spectrometry
- contrast enhanced
- patient reported outcomes
- spinal cord
- binding protein
- single cell
- middle aged
- energy transfer